See also this year's filing and all EDGAR filings for this company.
PDF Report 0001419041_2023_Forte_Biosciences_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001419041, Forte Biosciences Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 41,511,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 486,000 |
4 | LiabilitiesCurrent | 3,179,000 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 8,302,000 |
9 | ResearchAndDevelopmentExpense | 5,594,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 17,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 41,997,000 |
1 | Liabilities | 3,179,000 |
2 | Expenses | 13,896,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 38,818,000 |
5 | NetIncome | -13,879,000 |
6 | ComprehensiveNetIncome | -13,879,000 |
7 | BaseVar | 29,544,500 |
8 | EconomicCapitalRatio | 2.34 |